The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO Italy 2022 | The importance of achieving CR before stem cell transplantation in patients with AML and ALL
Francesco Lanza, MD, Romagna Transplant Network, Ravenna, Italy, explains why leukemic cells should ideally be eliminated from tissues before performing stem cell transplantation in patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), and further highlights the importance of carefully assessing measurable residual disease (MRD) in patients. This interview took place at the 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
